# 2026-01944: Importer of Controlled Substances Application: Sharp Clinical Services, LLC

2026-01944, Importer of Controlled Substances Application: Sharp Clinical Services, LLC, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2026-02-02, effective 2026-02-02 (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2026-01944
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-01944
- Title: Importer of Controlled Substances Application: Sharp Clinical Services, LLC
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 91 FR 4634
- Published: 2026-02-02
- Effective: 2026-02-02
- Comments close: 2026-03-04
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## Summary

Sharp Clinical Services, LLC wants to become an official importer of certain controlled substances, including some Schedule I drugs like Gamma Hydroxybutyric Acid and MDMA. This affects companies involved in drug manufacturing and regulation, who can comment or request a hearing by March 4, 2026. No fees or immediate changes yet, but this step could impact drug supply chains soon.

## Abstract

Sharp Clinical Services, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

## Effects PRIA read

- New Importer Seeks Schedule I Registration: mixed, low. Sharp Clinical Services, LLC applied on January 9, 2026 to be registered as an importer of four Schedule I controlled substances: Gamma Hydroxybutyric Acid (code 2010), 3,4‑Methylenedioxy‑methamphetamine (MDMA, code 7405), 5‑Methoxy‑N‑N‑dimethyltryptamine (code 7431), and Psilocybin (code 7437). Re…
- Import Use Limited; No Commercial Finished Drugs: cost, medium. The company plans to import the listed substances for distribution and clinical trials only; the registration would not authorize any other activities for these drug codes. The authorization explicitly will not extend to importing Food and Drug Administration‑approved or non‑approved finished dosag…

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2026-01944 on federalregister.gov](https://www.federalregister.gov/documents/2026/02/02/2026-01944/importer-of-controlled-substances-application-sharp-clinical-services-llc)
- [2026-01944 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-02-02/pdf/2026-01944.pdf)

## Related
- [Previous: 2026-01943, National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice o…](https://policyrisk.com/federal-register/2026-01943)
- [Next: 2026-01945, Marine Mammals; Proposed Incidental Harassment Authorization for Polar Bears in…](https://policyrisk.com/federal-register/2026-01945)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-01944 (as of 2026-06-08).
